Search research articles
Contact Us
Filters
Showing results (241-250 of 289) with videos related to
Page
of 29
Sort By:
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
July 29, 2024
Impact of Cardiac Resynchronization Therapy on Ventricular Arrhythmias and Survival After Durable Left Ventricular Assist Device Implantation
Connor P Oates, Luke L Lawrence, Grace E Bigham, et al.
Journal of Cardiac Failure
|
January 31, 2025
The Role of Lactate Metabolism in Heart Failure and Cardiogenic Shock: Clinical Insights and Therapeutic Implications
Melana Yuzefpolskaya, Sarah Schwartz, Annamaria Ladanyi, et al.
Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs
|
April 1, 2021
VE/VCO2 slope predicts RV dysfunction and mortality after left ventricular assist device: a fresh look at cardiopulmonary stress testing for prognostication
Jonathan Grinstein, Yazan Sawalha, Diego A Medvedofsky, et al.
Hepatology (Baltimore, Md.)
|
August 3, 2011
A protective antiarrhythmic role of ursodeoxycholic acid in an in vitro rat model of the cholestatic fetal heart
Michele Miragoli, Siti H Sheikh Abdul Kadir, Mary N Sheppard, et al.
Progress in Cardiovascular Diseases
|
July 1, 2022
Initiation of anti-hypertensive drugs and outcomes in patients with heart failure with preserved ejection fraction and persistent hypertension
Phillip H Lam, Apostolos Tsimploulis, Samir Patel, et al.
Future Cardiology
|
February 9, 2026
Acoramidis in transthyretin amyloid cardiomyopathy: expanding evidence from ATTRibute-CM
Nitasha Sarswat, Amrut V Ambardekar, Kevin M Alexander, et al.
JACC. Clinical Electrophysiology
|
December 28, 2020
Incidence of Cardiac Implantable Electronic Device Complications in Patients With Left Ventricular Assist Devices
Jasen L Gilge, Nicole Sbircea, Michael Z Tong, et al.
Journal of Cardiac Failure
|
May 22, 2026
Baroreflex activation therapy in heart failure - the Barostim-Enabled Neurohormonal Intervention for Improving Treatment of Heart Failure (BENEFIT-HF) trial rationale and design
Farooq H Sheikh, William T Abraham, Philip B Adamson, et al.
The American Journal of Cardiology
|
January 22, 2022
Low Blood Pressure Threshold for Adverse Outcomes During Left Ventricular Assist Device Support
Himabindu Vidula, Onur Altintas, Scott McNitt, et al.
CJC Open
|
June 22, 2026
Pregnancy Management and Outcomes with Hypertrophic Cardiomyopathy
Adhya Mehta, Sarah Schumacher, Rebekah Alison Bhansali, et al.
Page
of 29
Search research articles
Search
Showing results (241-250 of 289) with videos related to
Sort By:
Page
of 29
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
July 29, 2024
Impact of Cardiac Resynchronization Therapy on Ventricular Arrhythmias and Survival After Durable Left Ventricular Assist Device Implantation
Connor P Oates, Luke L Lawrence, Grace E Bigham, et al.
Journal of Cardiac Failure
|
January 31, 2025
The Role of Lactate Metabolism in Heart Failure and Cardiogenic Shock: Clinical Insights and Therapeutic Implications
Melana Yuzefpolskaya, Sarah Schwartz, Annamaria Ladanyi, et al.
Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs
|
April 1, 2021
VE/VCO2 slope predicts RV dysfunction and mortality after left ventricular assist device: a fresh look at cardiopulmonary stress testing for prognostication
Jonathan Grinstein, Yazan Sawalha, Diego A Medvedofsky, et al.
Hepatology (Baltimore, Md.)
|
August 3, 2011
A protective antiarrhythmic role of ursodeoxycholic acid in an in vitro rat model of the cholestatic fetal heart
Michele Miragoli, Siti H Sheikh Abdul Kadir, Mary N Sheppard, et al.
Progress in Cardiovascular Diseases
|
July 1, 2022
Initiation of anti-hypertensive drugs and outcomes in patients with heart failure with preserved ejection fraction and persistent hypertension
Phillip H Lam, Apostolos Tsimploulis, Samir Patel, et al.
Future Cardiology
|
February 9, 2026
Acoramidis in transthyretin amyloid cardiomyopathy: expanding evidence from ATTRibute-CM
Nitasha Sarswat, Amrut V Ambardekar, Kevin M Alexander, et al.
JACC. Clinical Electrophysiology
|
December 28, 2020
Incidence of Cardiac Implantable Electronic Device Complications in Patients With Left Ventricular Assist Devices
Jasen L Gilge, Nicole Sbircea, Michael Z Tong, et al.
Journal of Cardiac Failure
|
May 22, 2026
Baroreflex activation therapy in heart failure - the Barostim-Enabled Neurohormonal Intervention for Improving Treatment of Heart Failure (BENEFIT-HF) trial rationale and design
Farooq H Sheikh, William T Abraham, Philip B Adamson, et al.
The American Journal of Cardiology
|
January 22, 2022
Low Blood Pressure Threshold for Adverse Outcomes During Left Ventricular Assist Device Support
Himabindu Vidula, Onur Altintas, Scott McNitt, et al.
CJC Open
|
June 22, 2026
Pregnancy Management and Outcomes with Hypertrophic Cardiomyopathy
Adhya Mehta, Sarah Schumacher, Rebekah Alison Bhansali, et al.
Page
of 29